Highlights of the Best Science published in 2025

As 2025 comes to an end and with a new year about to begin, it is time for our annual retrospective on the most downloaded and cited articles from EuroIntervention.

The last year was a momentous one for the journal, and now more than ever, we extend our warmest thanks and best holiday wishes to our readers, authors, reviewers, and editors.

EuroIntervention celebrated an important milestone in 2025: its 20th anniversary. It was also a year of great achievement, reaching an Impact Factor of 9.5 and record submission numbers that have made article selection increasingly competitive. The journal’s quality has continued to rise steadily and significantly, a position we hope to maintain in 2026 along with our continued dedication to academic excellence and improving daily interventional practice.

Before we discover what the next year has in store, let us take a moment to look back on the articles that marked 2025 – from the standardisation of definitions and endpoints to the management of complex patient subsets and more.

Prof. Davide Capodanno - Editor in Chief

 

MOST CITED ORIGINAL RESEARCH

MOST CITED EXPERT CONSENSUS DOCUMENTS

Definitions and standardized endpoints for the use of drug-coated balloon in coronary artery disease: consensus document of the Drug Coated Balloon Academic Research Consortium

Fezzi Simone, Scheller Bruno, Cortese Bernardo, Alfonso Fernando, Jeger Raban, Colombo Antonio, Joner Michael, Shin Eun-Seok, Kleber Franz, Latib Azeem, Rissanen Tuomas, Eccleshall Simon, Ribichini Flavio, Tao Ling, Koo Bon-Kwon, Chieffo Alaide, Ge Junbo, Granada Juan, Stoll Hans-Peter, Spaulding Christian, Cavalcante Rafael, Abizaid Alexandre, Muramatsu Takashi, Boudoulas Konstantinos, Waksman Ron, Mehran Roxana, Cutlip Donald, Krucoff Mitchell, Stone Gregg, Garg Scot, Onuma Yoshinobu, Serruys Patrick
October 6, 2025 | 10.4244/EIJ-E-25-00021v

High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery

Schäfer Andreas, Alasnag Mirvat, Giacoppo Daniele, Collet Carlos, Rudolph Tanja, Roguin Ariel, Buszman Piotr, Colleran Róisín, Stefanini Giulio, Lefèvre Thierry, Mieghem Nicolas, Cayla Guillaume, Naber Christoph, Baumbach Andreas, Witkowski Adam, Burzotta Francesco, Capodanno Davide, Dudek Dariusz, Al-Lamee Rasha, Banning Adrian, MacCarthy Philip, Gottardi Roman, Schoenhoff Florian, Czerny Martin, Thielmann Matthias, Werner Nikos, Tarantini Giuseppe
Jan 6, 2025 | 10.4244/EIJ-D-23-01100

SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women

Baron Suzanne, Chou Josephine, Shah Tayyab, Vest Amanda, Abbott J. Dawn, Alasnag Mirvat, Aurigemma Cristina, Barbato Emanuele, Bellumkonda Lavanya, Bortnick Anna, Chieffo Alaide, van Geuns Robert-Jan, Grines Cindy, Halvorsen Sigrun, Hassager Christian, Kapur Navin, Naidu Srihari, Ng Vivian, Saw Jacqueline, Lansky Alexandra
May 20, 2025 | 10.4244/EIJ-D-24-01126
 
MOST DOWNLOADED STATE-OF-THE-ART REVIEWS

Management of complications after valvular interventions

Bansal Agam, Puri Rishi, Yun James, Krishnaswamy Amar, Jilaihawi Hasan, Makkar Raj, Kapadia Samir
April 21, 2025 | 10.4244/EIJ-D-24-00066

Mechanical circulatory support for complex, high-risk percutaneous coronary intervention

Ferro Enrico, Kim Joseph, Lalani Christina, Abbott Dawn, Yeh Robert
February 3, 2025 | 10.4244/EIJ-D-24-00386

Advances in coronary imaging of atherosclerotic plaques

Garcia-Garcia Hector, Sanz-Sánchez Jorge, Pinilla-Echeverri Natalia, Blanco Pablo, Bourantas Christos, Alfonso Fernando
July 21, 2025 | 10.4244/EIJ-D-24-00387
 
AUDIENCE-FAVORITE DEBATES

Routine diagnosis of ANOCA/INOCA: pros and cons

Montone Rocco, Caffè Andrea, Yasumura Keisuke, Kini Annapoorna
March 17, 2025 | 10.4244/EIJ-E-24-00072

Drug-coated balloon angioplasty for in-stent restenosis: pros and cons

Alfonso Fernando, Byrne Robert, Scheller Bruno, Van Belle Eric, Mehilli Julinda
January 20, 2025 | 10.4244/EIJ-E-24-00062

Could the age threshold for TAVI be relaxed to below 65 years? Pros and cons

Garot Philippe, Akodad Mariama, Marin-Cuartas Mateo, Borger Michael
April 21, 2025 | 10.4244/EIJ-E-24-00071
Receive our newsletter

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved